N
Patient 1
WHEN THE INVESTIGATION HAS BEEN COMPLETED PHILIPS WILL INFORM THE FDA.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALLURA XPER FD10 | SYSTEM, X-RAY, ANGIOGRAPHIC | PHILIPS HEALTHCARE | IZI | 722010 | 722010 | Y | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2018-12-21 | 0 |
Patient 1
WHEN THE INVESTIGATION HAS BEEN COMPLETED PHILIPS WILL INFORM THE FDA.
Patient 1
PHILIPS HAS RECEIVED THROUGH (B)(6) A REPORT SUBMITTED ((B)(4)) BY A CUSTOMER. IN THIS REPORT THE CUSTOMER REPORTED: ?THE X-RAY TUBE IN ROOM 5 HAD BEEN REPAIRED, UPDATED DURING THE DAY OF (B)(6) 2018. WAS REPORTED READY FOR USE. WE RE-BOOTED THE SYSTEM AT THE BEGINNING OF THE NIGHT SHIFT DUE TO THAT THE TABLE WAS HARD TO OPERATE (A CREAKING SOUND). HEREAFTER THERE WAS AN ACUTE PATIENT ON THE TABLE WITHOUT X-RAY PROBLEMS. AFTER SOME HOURS A NEW ACUTE PATIENT ARRIVE. BEFORE THIS PATIENT WAS BROUGHT ONTO THE TABLE WE DISCOVERED THAT THE TABLE WAS FLOATING ? MEANING THAT IT WAS MOVING BY THE LEASED TOUCH. THEREFORE IT WAS NOT POSSIBLE TO COMPLETE THE KAG/PCI ON THIS VERY BAD ACUTE PATIENT. HAD TO MOVE THE PATIENT TO ANOTHER ROOM WHICH TOOK APPROX. 10 MIN. NORMALLY ? WHEN TREATING ACUTE PATIENTS ? IT TAKES APPROX.. 5 MIN WHEN THE PATIENT ARRIVE AT THE ROOM UNTIL THE PROCEDURE CAN START?. PHILIPS HAS INITIATED AN INVESTIGATION OF THIS COMPLAINT.